CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
Recruiting · NCT07172256 · Registry updated 2026-07-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, neoplasm, squamous cell carcinoma | Recruiting | Phase 2 | 2026-07-30 | NCT07172256 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Cue Biopharma | 3 |
| National Cancer Institute (NCI) | 3015 |
| Yale University | 458 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Yale University | New Haven | United States | 76 |